{"id":779060,"date":"2023-08-21T10:02:37","date_gmt":"2023-08-21T14:02:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/"},"modified":"2023-08-21T10:02:37","modified_gmt":"2023-08-21T14:02:37","slug":"neurostar-advanced-therapy-wins-2023-dotcomm-awards","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/","title":{"rendered":"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards"},"content":{"rendered":"<h2>\nAward Acknowledges Excellence in Digital Marketing Efforts<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">MALVERN, Pa., Aug.  21, 2023  (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is thrilled to announce NeuroStar Advanced Therapy\u2019s \u201cTap Into A New Possibility for Depression\u201d campaign has been awarded Gold by the 2023 dotCOMM Awards in the category of Digital Marketing &amp; Communication Campaigns.<\/p>\n<p>\u201cThis award is a recognition of our efforts to not only raise awareness about NeuroStar, but to also educate patients and guide their path to treatment. A priority for us as a company is to make it easy for patients to get the help they need, and to support the physician practices that are in the trenches, fighting depression alongside these patients each day,\u201d stated Lisa Metzner-Rosas, Senior Vice President, Chief Marketing Officer, of Neuronetics Inc. \u201cWe look forward to evolving our campaign and strategy to support even more customers and their patients this year.\u201d<\/p>\n<p>The dotCOMM Awards is an annual international competition that honors merit in web creativity and digital communication. Administered and judged by the Association of Marketing and Communication Professionals (AMCP), a globally renowned and esteemed evaluator of creative work, the awards celebrate the best achievements in the field. There were over 2,500 entries from throughout the United States, Canada and internationally across 241 categories.<\/p>\n<p>Neuronetics\u2019 marketing team, with creative partner Hyperquake, has recently\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QPCx2nvnuQ8OT9WFRGkKyFoRyw6ng4aYSZK9uU7kgd1rCpv1K12Tysk-ybPk1rQGjvZAi67N7tUQ0w6rrVvRCnWzqT_Wr--d2EF-IRcfJYUGfyIllrCx2wBvNNzwe9wPBh_nPKRQrNEcxUXQWqV6FsHCTGvatyHBm1G2oMzC3iQq1QJDllHK_OSBdoiaJSlJT8-9cMMfX4GNaYcQCzzl1iBhtJ-cZYfPU0yTEgrXM0NWQ2eHzH5Cg3sYGn9TVTR8vuiFfysKFK8D9VCZdVmuTg==\" rel=\"nofollow noopener\" target=\"_blank\">expanded<\/a>\u00a0the \u201cTap Into A New Possibility for Depression\u201d campaign, shifting the spotlight onto the inspirational journeys of numerous patients who triumphed over depression and found their way to recovery with the help of NeuroStar Advanced Therapy.<\/p>\n<p>For more information about NeuroStar TMS Therapy, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8UoOjP9_3wHWMHBzb7nV7FOQIllxdSBmiAIeZPqnhhGy36_yQOEjWFm5aEk3YNb2Et3WYaBz4BNk13W22uRAFA==\" rel=\"nofollow noopener\" target=\"_blank\">NeuroStar.com<\/a>.\u00a0<\/p>\n<p>\n        <strong>About<\/strong><br \/>\n        <strong>Neuronetics<\/strong><br \/>\n        <br \/>Neuronetics, Inc.\u00a0believes that mental health is as important as physical health. As a global leader in neuroscience,\u00a0Neuronetics\u00a0is redefining patient and physician expectations with its NeuroStar Advanced Therapy for Mental Health. NeuroStar is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication hasn\u2019t helped. NeuroStar is FDA-cleared for adults with major depressive disorder (MDD), as an adjunct for adults with obsessive-compulsive disorder (OCD), and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression). NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 5.6 million treatments delivered. NeuroStar is backed by the largest clinical data set of any TMS system for depression, including the world\u2019s largest depression Outcomes Registry.\u00a0Neuronetics\u00a0is committed to transforming lives by offering an exceptional treatment that produces extraordinary results. For safety and prescribing information,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ewBKrKmnW6SEtOBcKW3t8a4Bngt2gk6XwGL9LaDg7Lv4sjqDNcJ-VghiQ05qmaYnbipNTsj34aYQeEw3tKrIf7Hta6r5UT6CeNyvCwfFkGg2BuJ7Wg-dfvmXosLB7d1z9cyz1jR-VVaQU6yRylTmPV2NLg-IQ8CyTKeL7tw75RNS4ezXtFW7GrlOIet8YZehD2kDNpnDxDyNIymfLkxxiQhWuGjuHNl5Q6F3Eev6Wl8=\" rel=\"nofollow noopener\" target=\"_blank\"><strong>www.neurostar.com<\/strong><\/a>.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>EvolveMKD<br \/>646.517.4220<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8UoOjP9_3wHWMHBzb7nV7APYWL6xpOKZeagPNDEmHtqH-c5vgeWMSqJhlqA7lUEQFlC8LTsC-wZLIqTzdg247wixxsHeTEOF-sgvmE8cK00=\" rel=\"nofollow noopener\" target=\"_blank\">NeuroStar@evolvemkd.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YmQyY2Q4YjYtMmYyMi00NDk5LTlhMmMtN2EzNzlkYTkwNjIzLTExMjIwMTE=\/tiny\/Neuronetics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Award Acknowledges Excellence in Digital Marketing Efforts MALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is thrilled to announce NeuroStar Advanced Therapy\u2019s \u201cTap Into A New Possibility for Depression\u201d campaign has been awarded Gold by the 2023 dotCOMM Awards in the category of Digital Marketing &amp; Communication Campaigns. \u201cThis award is a recognition of our efforts to not only raise awareness about NeuroStar, but to also educate patients and guide their path to treatment. A priority for us as a company is to make it easy for patients to get the help &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-779060","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Award Acknowledges Excellence in Digital Marketing Efforts MALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is thrilled to announce NeuroStar Advanced Therapy\u2019s \u201cTap Into A New Possibility for Depression\u201d campaign has been awarded Gold by the 2023 dotCOMM Awards in the category of Digital Marketing &amp; Communication Campaigns. \u201cThis award is a recognition of our efforts to not only raise awareness about NeuroStar, but to also educate patients and guide their path to treatment. A priority for us as a company is to make it easy for patients to get the help &hellip; Continue reading &quot;NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-21T14:02:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards\",\"datePublished\":\"2023-08-21T14:02:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/\"},\"wordCount\":462,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/\",\"name\":\"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA=\",\"datePublished\":\"2023-08-21T14:02:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/","og_locale":"en_US","og_type":"article","og_title":"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards - Market Newsdesk","og_description":"Award Acknowledges Excellence in Digital Marketing Efforts MALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is thrilled to announce NeuroStar Advanced Therapy\u2019s \u201cTap Into A New Possibility for Depression\u201d campaign has been awarded Gold by the 2023 dotCOMM Awards in the category of Digital Marketing &amp; Communication Campaigns. \u201cThis award is a recognition of our efforts to not only raise awareness about NeuroStar, but to also educate patients and guide their path to treatment. A priority for us as a company is to make it easy for patients to get the help &hellip; Continue reading \"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-21T14:02:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards","datePublished":"2023-08-21T14:02:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/"},"wordCount":462,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/","name":"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA=","datePublished":"2023-08-21T14:02:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg5NTMwMCM1NzU3NzE2IzIxMTA0NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-wins-2023-dotcomm-awards\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/779060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=779060"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/779060\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=779060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=779060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=779060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}